| |
Latest 10 SEC filings (by transaction date) for APVO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 4/24 | Taylor Daphne | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -1,584 | |
Mar 5/24 | Mar 4/24 | Taylor Daphne | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,584 | |
Mar 5/24 | Mar 3/24 | Lamothe Jeffrey G. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 3/24 | Lamothe Jeffrey G. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,667 | |
Mar 5/24 | Mar 3/24 | Kwon SoYoung | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 3/24 | Kwon SoYoung | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,667 | |
Mar 5/24 | Mar 3/24 | White Marvin L | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -9,584 | |
Mar 5/24 | Mar 3/24 | White Marvin L | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 9,584 | |
Mar 5/24 | Mar 2/24 | Taylor Daphne | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 2/24 | Taylor Daphne | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,667 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for APVO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 4/24 | Taylor Daphne | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -1,584 | |
Mar 5/24 | Mar 2/24 | Taylor Daphne | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 4/24 | Taylor Daphne | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,584 | |
Mar 5/24 | Mar 2/24 | Taylor Daphne | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,667 | |
Mar 5/24 | Mar 3/24 | Lamothe Jeffrey G. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 2/24 | Lamothe Jeffrey G. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -5,500 | |
Mar 5/24 | Mar 3/24 | Lamothe Jeffrey G. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,667 | |
Mar 5/24 | Mar 2/24 | Lamothe Jeffrey G. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,500 | |
Mar 5/24 | Mar 3/24 | Kwon SoYoung | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Mar 5/24 | Mar 2/24 | Kwon SoYoung | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,667 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |